Clinical outcomes related to interface type in patients with obstructive sleep apnea/hypopnea syndrome who are using continuous positive airway pressure

Chest

Volumn 123, Issue 4, 2003, Pages 1112-1118

  Massie, Clifford A ^a,b   Hart, Robert W ^a  

^a Ctr Sleep Hlth Suburban Lung A   (United States)

^b Suburban Lung Associates   (United States)

Author keywords

Complianee; Continuous positive airway pressure; Interface; Obstructive sleep apnea

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DESENSITIZATION; FEMALE; HUMAN; MALE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT SATISFACTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESIDUAL VOLUME; SCORING SYSTEM; SLEEP APNEA SYNDROME; SLEEP DISORDER;

EID: 0037390204     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.4.1112     Document Type: Article

References (30)

1. Sanders MH, Gruendl CA, Rogers RM. Patient compliance with nasal CPAP therapy for sleep apnea. Chest 1986; 90:330-333
2. Pepin JL, Leger P, Veale D, et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Chest 1995; 107:375-381
3. Kalan A, Kenyon GS, Seemungal TAR, et al. Adverse effects of nasal continuous positive airway pressure therapy in sleep apnoea syndrome. J Laryngol Otol 1999; 113:888-892
4. Engleman HM, Asgari-Jirhandeh N, McLeod AL, et al. Self-reported use of CPAP, and benefits of CPAP therapy. Chest 1996; 109:1470-1476
5. Janson C, Noges E, Svedberg-Brandt S, et al. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment? Respir Med 2000; 94:145-149
6. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147:887-895
7. Weaver TE, Kribbs NB, Pack AI, et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 1997; 20:278-283
8. McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159:1108-1114
9. Mortimore IL, Whittle AT, Douglas NJ. Comparison of nose and face mask CPAP therapy for sleep apnea. Thorax 1998; 53:290-292
10. Martins De Araujo MT, Vieira SB, Vasquez EC, et al. Heated humidification or face mask to prevent upper airway dryness during continuous positive airway pressure therapy. Chest 2000; 117:142-147
11. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22:667-689
12. Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997; 20:835-843
13. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14:540-545
14. American Sleep Disorders Association Report. Practice parameters for the indications for polysomnography and related procedures. Sleep 1997; 20:406-422
15. Rauscher H, Formanek D, Popp W, et al. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993; 103:1675-1680
16. Meslier N, Lebrun T, Grillier-Lanoir V, et al. A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 1998; 12:185-192
17. Series F, Mare I, Cormier Y, et al. Required levels of nasal continuous positive airway pressure during treatment of obstructive sleep apnoea. Eur Respir J 1994; 7:1776-1781
18. Teschler H, Berthon-Jones M, Thompson AB, et al. Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Am Respir Crit Care Med 1996; 154:734-740
19. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116:1545-1549
20. Jokic R, Klimaszewski A, Sridhar G, et al. Continuous positive airway pressure requirement during the first month of treatment in patients with severe obstructive sleep apnea. Chest 1998; 114:1061-1069
21. D'Ambrosio C, Bowman T, Mohsenin V. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure; a prospective study. Chest 1999; 115:123-129
22. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343:572-575
23. Jenkinson C, Davies RJO, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized prospective parallel trial. Lancet 1999; 353:2100-2105
24. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoe/hypopnoea syndrome. Lancet 1994; 343:572-575
25. Teschler H, Wessendorf TE, Farhat AA, et al. Two months auto-adjusting vs conventional nCPAP for obstructive sleep apnoea syndrome. Eur Respir J 2000; 15:990-995
26. Massie CA, Hart RW, Peralez K, et al. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999; 116:403-408
27. Hoy CJ, Vennelle M, Kingshott RN, et al. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999; 159:1096-1100
28. Hudgel DW, Fung C. A long-term randomized, cross-over comparison of auto-titrating and standard nasal continuous airway pressure. Sleep 2000; 23:645-648
29. Pepin JL, Krieger J, Rodenstein D, et al. Effective compliance during the first 3 months of continuous positive airway pressure. Am J Respir Crit Care Med 1999; 160:1124-1129
30. Popescu G, Latham M, Allgar V, et al. Continuous positive airway pressure for sleep apnea/hypopnea syndrome: usefulness of a 2 week trial to identify factors associated with long term use. Thorax 2001; 56:727-733